InvestorsHub Logo
icon url

lasers

02/01/17 6:19 AM

#241230 RE: The ELTP King #241229

IMO Embeda is still very much at risk at being unstable. I also found no mention of Embeda in Pfizer latest Qtr filing.

Why mess with Embeda and Troxyca and possible lawsuits, when Pfizer has now acquired Hospira.
icon url

lasers

02/01/17 6:47 AM

#241232 RE: The ELTP King #241229

Yes Embeda can be prescribed. However the Pharmacy that I spoke to said that they do not stock it and it would be a special order taking a few days to receive. IMO Prescribers do not trust Embeda's stability and do not want to risk the safety.

If Embeda sales are very low then it would not be economical for Pfizer to manufacture.

Pfizer's Hospira opioid injectables appears to be Pfizer's concentration.

Pfizer is not forthcoming on any Embeda or Troxyca information updates.
icon url

jour_trader

02/01/17 6:52 AM

#241233 RE: The ELTP King #241229

Pfizer isn't obligated to disclose anything about Troxyca or Embeda. I looked quickly through the last several transcripts of investor conferences through NASDAQ IR and they weren't mentioned there either.
icon url

NASDAQ2020

02/01/17 7:45 AM

#241236 RE: The ELTP King #241229

Most Drs think Embeda is unstable and yanked from the market.
Marketing 101 to re educate .
Maybe Pfizer can use Elite/Puracap's marketing team and get some sales, GL